Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryogo Minamimoto

Showing results (81-90 of 148) with videos related to

Pageof 15
Sort By:
Kaku Igaku. the Japanese Journal of Nuclear Medicine|July 30, 2009
[Assessment of diagnostic criteria for FDG-PET cancer screening program according to the interpretation of FDG-PET and combined examination]Ryogo Minamimoto, Michio Senda, Seishi Jinnouchi, et al.
Nuclear Medicine Communications|November 6, 2014
Volumetric comparison of positron emission tomography/computed tomography using 4'-[methyl-¹¹C]-thiothymidine with 2-deoxy-2-¹⁸F-fluoro-D-glucose in patients with advanced head and neck squamous cell carcinomaKimiteru Ito, Junkichi Yokoyama, Yoko Miyata, et al.
EJNMMI Reports|March 10, 2025
Assessing large language models for Lugano classification of malignant lymphoma in Japanese FDG-PET reportsRintaro Ito, Keita Kato, Kosuke Nanataki, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|January 21, 2021
Differentiating Dementia with Lewy Bodies and Alzheimer's Disease by Deep Learning to Structural MRIKiyotaka Nemoto, Hiromasa Sakaguchi, Wataru Kasai, et al.
Nuclear Medicine and Biology|April 16, 2011
Effects of blood glucose level on FDG uptake by liver: a FDG-PET/CT studyKazuo Kubota, Hiroshige Watanabe, Yuji Murata, et al.
Abdominal Radiology (New York)|April 4, 2016
Comparison of 11C-4DST and 18F-FDG PET/CT imaging for advanced renal cell carcinoma: preliminary studyRyogo Minamimoto, Noboru Nakaigawa, Yoji Nagashima, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|March 22, 2014
Prognostic value of post-treatment (18)F-FDG PET/CT for advanced head and neck cancer after combined intra-arterial chemotherapy and radiotherapyKimiteru Ito, Keigo Shimoji, Yoko Miyata, et al.
Nuclear Medicine Communications|September 1, 2025
Predictive factors for the efficacy of radioiodine therapy in patients with Graves' diseaseHaruna Iwanaga, Naotoshi Fujita, Shinji Abe, et al.
Annals of Nuclear Medicine|January 16, 2010
F-18 FDG PET/CT evaluation of radiotherapy response in rare case of mucosa-associated lymphoid tissue lymphomaRyogo Minamimoto, Ukihide Tateishi, Naoto Tomita, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 12, 2015
Biodistribution of the ¹⁸F-FPPRGD₂ PET radiopharmaceutical in cancer patients: an atlas of SUV measurementsRyogo Minamimoto, Mehran Jamali, Amir Barkhodari, et al.
Pageof 15

Showing results (81-90 of 148) with videos related to

Sort By:
Pageof 15
Kaku Igaku. the Japanese Journal of Nuclear Medicine|July 30, 2009
[Assessment of diagnostic criteria for FDG-PET cancer screening program according to the interpretation of FDG-PET and combined examination]Ryogo Minamimoto, Michio Senda, Seishi Jinnouchi, et al.
Nuclear Medicine Communications|November 6, 2014
Volumetric comparison of positron emission tomography/computed tomography using 4'-[methyl-¹¹C]-thiothymidine with 2-deoxy-2-¹⁸F-fluoro-D-glucose in patients with advanced head and neck squamous cell carcinomaKimiteru Ito, Junkichi Yokoyama, Yoko Miyata, et al.
EJNMMI Reports|March 10, 2025
Assessing large language models for Lugano classification of malignant lymphoma in Japanese FDG-PET reportsRintaro Ito, Keita Kato, Kosuke Nanataki, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|January 21, 2021
Differentiating Dementia with Lewy Bodies and Alzheimer's Disease by Deep Learning to Structural MRIKiyotaka Nemoto, Hiromasa Sakaguchi, Wataru Kasai, et al.
Nuclear Medicine and Biology|April 16, 2011
Effects of blood glucose level on FDG uptake by liver: a FDG-PET/CT studyKazuo Kubota, Hiroshige Watanabe, Yuji Murata, et al.
Abdominal Radiology (New York)|April 4, 2016
Comparison of 11C-4DST and 18F-FDG PET/CT imaging for advanced renal cell carcinoma: preliminary studyRyogo Minamimoto, Noboru Nakaigawa, Yoji Nagashima, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|March 22, 2014
Prognostic value of post-treatment (18)F-FDG PET/CT for advanced head and neck cancer after combined intra-arterial chemotherapy and radiotherapyKimiteru Ito, Keigo Shimoji, Yoko Miyata, et al.
Nuclear Medicine Communications|September 1, 2025
Predictive factors for the efficacy of radioiodine therapy in patients with Graves' diseaseHaruna Iwanaga, Naotoshi Fujita, Shinji Abe, et al.
Annals of Nuclear Medicine|January 16, 2010
F-18 FDG PET/CT evaluation of radiotherapy response in rare case of mucosa-associated lymphoid tissue lymphomaRyogo Minamimoto, Ukihide Tateishi, Naoto Tomita, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 12, 2015
Biodistribution of the ¹⁸F-FPPRGD₂ PET radiopharmaceutical in cancer patients: an atlas of SUV measurementsRyogo Minamimoto, Mehran Jamali, Amir Barkhodari, et al.
Pageof 15